Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BAL PHARMA JUBILANT PHARMOVA BAL PHARMA/
JUBILANT PHARMOVA
 
P/E (TTM) x 40.8 -2,647.7 - View Chart
P/BV x 2.3 1.7 134.7% View Chart
Dividend Yield % 1.1 0.9 124.6%  

Financials

 BAL PHARMA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    BAL PHARMA
Mar-23
JUBILANT PHARMOVA
Mar-23
BAL PHARMA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs134496 27.1%   
Low Rs63269 23.6%   
Sales per share (Unadj.) Rs193.9394.4 49.2%  
Earnings per share (Unadj.) Rs1.7-4.1 -41.0%  
Cash flow per share (Unadj.) Rs7.530.7 24.4%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Avg Dividend yield %1.01.3 77.4%  
Book value per share (Unadj.) Rs40.7338.6 12.0%  
Shares outstanding (eoy) m15.69159.28 9.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.51.0 52.6%   
Avg P/E ratio x59.2-93.8 -63.0%  
P/CF ratio (eoy) x13.212.4 106.0%  
Price / Book Value ratio x2.41.1 215.2%  
Dividend payout %59.9-122.7 -48.8%   
Avg Mkt Cap Rs m1,54960,873 2.5%   
No. of employees `000NANA-   
Total wages/salary Rs m55321,660 2.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,04262,817 4.8%  
Other income Rs m9383 2.5%   
Total revenues Rs m3,05263,201 4.8%   
Gross profit Rs m2537,317 3.5%  
Depreciation Rs m915,540 1.6%   
Interest Rs m1231,882 6.5%   
Profit before tax Rs m47278 17.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m21927 2.3%   
Profit after tax Rs m26-649 -4.0%  
Gross profit margin %8.311.6 71.3%  
Effective tax rate %44.8333.5 13.4%   
Net profit margin %0.9-1.0 -83.4%  
BALANCE SHEET DATA
Current assets Rs m2,28237,624 6.1%   
Current liabilities Rs m2,09317,724 11.8%   
Net working cap to sales %6.231.7 19.5%  
Current ratio x1.12.1 51.3%  
Inventory Days Days825 31.2%  
Debtors Days Days1,12856 2,018.8%  
Net fixed assets Rs m82971,668 1.2%   
Share capital Rs m157159 98.6%   
"Free" reserves Rs m48153,772 0.9%   
Net worth Rs m63853,931 1.2%   
Long term debt Rs m30531,104 1.0%   
Total assets Rs m3,110109,292 2.8%  
Interest coverage x1.41.1 120.7%   
Debt to equity ratio x0.50.6 83.0%  
Sales to assets ratio x1.00.6 170.2%   
Return on assets %4.81.1 425.6%  
Return on equity %4.1-1.2 -341.3%  
Return on capital %18.12.5 712.3%  
Exports to sales %66.40-   
Imports to sales %22.44.1 549.7%   
Exports (fob) Rs m2,020NA-   
Imports (cif) Rs m6832,564 26.6%   
Fx inflow Rs m2,0207,100 28.5%   
Fx outflow Rs m7162,564 27.9%   
Net fx Rs m1,3054,536 28.8%   
CASH FLOW
From Operations Rs m-186,607 -0.3%  
From Investments Rs m-222-5,444 4.1%  
From Financial Activity Rs m244-1,567 -15.6%  
Net Cashflow Rs m4301 1.2%  

Share Holding

Indian Promoters % 47.1 47.4 99.4%  
Foreign collaborators % 4.2 3.3 126.1%  
Indian inst/Mut Fund % 0.1 23.2 0.6%  
FIIs % 0.1 20.3 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.8 49.3 98.9%  
Shareholders   15,060 86,588 17.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BAL PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BAL PHARMA vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BAL PHARMA vs Jubilant Pharmova Share Price Performance

Period BAL PHARMA Jubilant Pharmova S&P BSE HEALTHCARE
1-Day -4.40% -0.54% 1.18%
1-Month -17.76% 2.20% -0.75%
1-Year 40.93% 109.28% 61.82%
3-Year CAGR 19.04% -6.79% 18.16%
5-Year CAGR 5.43% -2.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the BAL PHARMA share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of BAL PHARMA hold a 51.2% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BAL PHARMA and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, BAL PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 59.9%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of BAL PHARMA, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.